| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/07/2000 | WO2000041681A3 MEDICINAL FORMULATIONS CONTAINING AN OPIOID AND AN α-ANTAGONIST |
| 12/07/2000 | WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 12/07/2000 | DE19925613A1 Verbundlaminat und Verfahren zu seiner Herstellung A composite laminate and method of production |
| 12/07/2000 | DE19925339A1 Verfahren und Vorrichtung zum Herstellen eines Produktes aus Streifenband, insbesondere eines medizinischen und/oder wirkstoffhaltigen Produktes sowie befüllbaren Behältern oder Siegelrandbeuteln Method and apparatus for manufacturing a product from strip tape, especially a medicinal and / or active substance-containing product as well as fillable containers or sachets |
| 12/07/2000 | DE19925338A1 Substratabschnitte mit erhöhter Lagerstabilität während ihrer Lagerung in Beutelverpackung, sowie Verfahren zu ihrer Herstellung Substrate portions with increased storage stability during storage in bag packaging, as well as processes for their preparation |
| 12/07/2000 | DE19925290A1 Stable, well-tolerated composition for intranasal administration of water-insoluble drugs e.g. scopolamine, comprising solution of drug in neutral oil, especially triglyceride |
| 12/07/2000 | DE19925289A1 Stable, well-tolerated composition for intranasal administration of water-soluble drugs, e.g. nicotine, comprising drug, neutral oil (preferably triglyceride) and optionally solubilizer |
| 12/07/2000 | DE19925211A1 Kit for preparing stable paclitaxel formulation for use as anticancer agent, comprising separately stored drug, solution of anhydrous citric acid in ethanol and solution of polyethoxylated castor oil in ethanol |
| 12/07/2000 | DE19925199A1 Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie Cytotoxic T cell epitopes of the papillomavirus L1 protein and its use in diagnosis and therapy |
| 12/07/2000 | DE19925143A1 Neue liposomale Vektorkomplexe und deren Verwendung für die Gentherapie New liposomal vector complexes and their use for gene therapy |
| 12/07/2000 | DE19925001A1 Stable liquid concentrate for preparing orally administered multiphase controlled drug release formulation, comprising water-miscible coherent phase and disperse phase releasing drug e.g. amoxicillin on dilution |
| 12/07/2000 | DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms |
| 12/07/2000 | CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
| 12/07/2000 | CA2375829A1 Keratinocyte growth factor-2 formulations |
| 12/07/2000 | CA2375802A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy |
| 12/07/2000 | CA2375779A1 Lyophilized hgf preparation |
| 12/07/2000 | CA2375237A1 Method of sterilizing |
| 12/07/2000 | CA2375123A1 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 12/07/2000 | CA2374946A1 Balsam for the treatment of surface burns and chafing rashes |
| 12/07/2000 | CA2374897A1 Compositions of a-beta peptide and processes for producing same |
| 12/07/2000 | CA2374310A1 Nutritional supplements |
| 12/07/2000 | CA2374288A1 Novel formulations comprising lipid-regulating agents |
| 12/07/2000 | CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues |
| 12/07/2000 | CA2374119A1 Method and composition for masking mineral taste |
| 12/07/2000 | CA2374117A1 Novel formulations comprising lipid-regulating agents |
| 12/07/2000 | CA2373738A1 Fibrin polymer structure |
| 12/07/2000 | CA2373726A1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area |
| 12/07/2000 | CA2373635A1 Method of producing submicron particles of a labile agent |
| 12/07/2000 | CA2371247A1 Substantially oil-free cyclosporin compositions |
| 12/07/2000 | CA2371033A1 Injectable anesthetic formulation |
| 12/07/2000 | CA2370364A1 Sunscreen composition containing sol-gel microcapsules |
| 12/07/2000 | CA2368192A1 Preparations for the application of antiseptic agents to the interior of the human or animal body |
| 12/06/2000 | EP1057862A2 Polymer film compositions for capsules |
| 12/06/2000 | EP1057832A1 Substance having steroid-like structure, process for the production thereof and antitumor agents containing the same |
| 12/06/2000 | EP1057828A2 Trovafloxacin oral suspensions |
| 12/06/2000 | EP1057480A2 Transdermal estrogen agonist-antagonist therapy |
| 12/06/2000 | EP1057479A1 Pharmaceutical tablet formulations for direct compression |
| 12/06/2000 | EP1057478A2 Thermoplastic polymer membranes |
| 12/06/2000 | EP1057472A1 Solid preparation for oral hygiene |
| 12/06/2000 | EP1057414A1 Sugar-free hard coatings prepared from liquid mixtures of erythritol and sorbitol |
| 12/06/2000 | EP1056839A1 Pharmaceutical formulation containing a microbial enzyme which digests hyaluronic acid |
| 12/06/2000 | EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 12/06/2000 | EP1056731A1 Amino acid derivatives of daryl 1,3,4-oxadiazolone |
| 12/06/2000 | EP1056673A1 Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile |
| 12/06/2000 | EP1056515A1 Radioactive stent |
| 12/06/2000 | EP1056503A1 Thin film radiation source |
| 12/06/2000 | EP1056486A1 A synthetic biomaterial compound |
| 12/06/2000 | EP1056477A1 Nanoparticles comprising polyisobutylcyanoacrylate and cyclodextrins |
| 12/06/2000 | EP1056473A1 Targeted delivery of biologically active media |
| 12/06/2000 | EP1056469A1 Novel peptide copolymer compositions |
| 12/06/2000 | EP1056467A2 Method for the treatment of diseases or disorders of the inner ear |
| 12/06/2000 | EP1056462A1 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 12/06/2000 | EP1056457A1 S-lansoprazole compositions and methods |
| 12/06/2000 | EP1056448A1 Pharmaceutical combinations containing tramadol |
| 12/06/2000 | EP1056445A1 Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 12/06/2000 | EP1056444A1 Stable shaped particles of crystalline organic compounds |
| 12/06/2000 | EP1056443A1 Butorphanol sustained release formulations |
| 12/06/2000 | EP1056442A1 Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 12/06/2000 | EP1056438A1 Oral care compositions comprising chlorite and methods |
| 12/06/2000 | EP1021137A4 Drug delivery system |
| 12/06/2000 | EP0918513B1 Easy to swallow oral medicament composition |
| 12/06/2000 | EP0772443B1 Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease |
| 12/06/2000 | EP0758885B1 Hydrophilic, hot-melt-type pressure-sensitive adhesive |
| 12/06/2000 | EP0683670B1 Wound-healing compositions containing iodine and a sugar |
| 12/06/2000 | EP0680317A4 Method for treating a medical patient for cardiac trauma |
| 12/06/2000 | CN1276009A Electric coated microgranules for stabilizing lactic acid bacteria |
| 12/06/2000 | CN1275916A Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 12/06/2000 | CN1275914A Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 12/06/2000 | CN1275913A Intra-cancer-cell nuclease activator |
| 12/06/2000 | CN1275910A Therapeutic agents |
| 12/06/2000 | CN1275908A Preparation of directly mouldable tabletting auxiliary |
| 12/06/2000 | CN1275905A Solid preparation for oral hygiene |
| 12/06/2000 | CN1275900A Cosmetic formulations for the prevention and therapy or hair loss |
| 12/06/2000 | CN1275889A Improved chewing gum formulations including aspartame and sodium bicarbonate |
| 12/06/2000 | CN1275887A Chewing gum containing physiological cooling agents |
| 12/06/2000 | CN1275394A Pumpkin cream and productive process thereof |
| 12/06/2000 | CN1275379A Plaster for treating burn and scald and preparation process thereof |
| 12/06/2000 | CN1275375A Process for preparation of spraying granule of ovoflavin |
| 12/06/2000 | CN1275335A Stable foam composition |
| 12/06/2000 | CN1059119C Traditional Chinese medicine for treating various headache and preparation process thereof |
| 12/06/2000 | CN1059117C Katsutoxin pill for tumor and preparation process thereof |
| 12/06/2000 | CN1059109C Traditional Chinese medicine for treating ascites ue to cirrhosis |
| 12/06/2000 | CN1059101C Pill made of eight Chinese medicinal herbs for treating enteritis |
| 12/06/2000 | CN1059100C Ointment for subsidence of swelling and relieving pain |
| 12/06/2000 | CN1059097C Channel tropism powder |
| 12/06/2000 | CN1059095C Medicine for treating infectious oral disease |
| 12/06/2000 | CN1059094C Epilepsy pill and producing process thereof |
| 12/06/2000 | CN1059093C Thyroid gland pill and producing process thereof |
| 12/06/2000 | CN1059092C Medicine liquid for burns |
| 12/06/2000 | CN1059091C Medicine for treating fracture and bone disease, and preparation process thereof |
| 12/06/2000 | CN1059088C Powder preparation for healing damaged skin |
| 12/06/2000 | CN1059080C Whitebait refinished capsule and its preparation |
| 12/05/2000 | US6156792 Calcium mupirocin non-aqueous nasal spray for otitis media or for recurrent acute bacterial sinusitis |
| 12/05/2000 | US6156773 Pharmaceutical composition |
| 12/05/2000 | US6156753 Local administration of type III phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 12/05/2000 | US6156742 Emergency contraceptive kit |
| 12/05/2000 | US6156492 Adsorbent carrier containing immobilized sulfated polysaccharide and ligand for direct hemoperfusion |
| 12/05/2000 | US6156348 Administering to mucosal membrane therapeutic or diagnostic agent in carrier within microsphere, surface of microsphere comprising polymer having anhydride oligomer incorporated which improves adhesion of polymer to mucosal membrane |
| 12/05/2000 | US6156347 Controlled release chromium picolinate |
| 12/05/2000 | US6156346 Urease-responsive delivery systems for diagnostic and therapeutic applications |